The purpose of this study is to examine the safety and influence of an intervention
(COGNUTRIN) using nutritional supplements (n-3 fatty acids and blueberry anthocyanins) on
cognitive performance in breast cancer survivors following chemotherapy. The investigators'
goal is to treat or lessen the late effects of cancer treatment. The supplement to be used
will be a combination of the following: (1) VitaBlue (40% polyphenolics, 12.5% anthocyanins
from blueberries (BB) and (2) n-3 fatty acids - Lovaza.
Phase:
Early Phase 1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborators:
Gateway for Cancer Research University of South Florida